Organogenesis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Organogenesis and other ETFs, options, and stocks.About ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
CEOGary S. Gillheeney
CEOGary S. Gillheeney
Employees869
Employees869
HeadquartersCanton, Massachusetts
HeadquartersCanton, Massachusetts
Founded1985
Founded1985
Employees869
Employees869
ORGO Key Statistics
Market cap629.22M
Market cap629.22M
Price-Earnings ratio-42.39
Price-Earnings ratio-42.39
Dividend yield—
Dividend yield—
Average volume1.02M
Average volume1.02M
High today$4.98
High today$4.98
Low today$4.85
Low today$4.85
Open price$4.93
Open price$4.93
Volume645.81K
Volume645.81K
52 Week high$6.71
52 Week high$6.71
52 Week low$2.61
52 Week low$2.61
ORGO News
TipRanks 6d
Buy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market PositioningIn a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Organogenesis Holdings, with a price target of $7.00. Elevate Your Investing...
People also own
Based on the portfolios of people who own ORGO. This list is generated using Robinhood data, and it’s not a recommendation.